Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-06

FDA Approved: EYE ALLERGY ITCH RELIEF — Original Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved the original ANDA for Eye Allergy Itch Relief containing olopatadine hydrochloride ophthalmic solution, a generic version of an ocular allergy medi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYE ALLERGY ITCH RELIEF (Olopatadine hydrochloride ophthalmic solution)

Snippet

ORIG AP for EYE ALLERGY ITCH RELIEF (OLOPATADINE HYDROCHLORIDE OPHTHALMIC)